Dear Colleagues,

Curcumin, a hydrophobic and polyphenolic compound extracted from the perennial herb Curcuma longa, is used in various biomedical applications. Curcumin has antioxidant, antimicrobial, anti-inflammatory, and neuroprotective effects on human and animal health; it has several limitations, including poor water solubility and an unstable chemical structure, rapid metabolization but poor absorption in the body, as well as differing utilization and bioavailability depending on the species and sex of the organism. In this regard, curcumin in the form of a nanoparticle has been widely reported to enhance the bioavailability and solubility of lipophilic curcumin. In recent years, several studies have shown the beneficial effects of nanocurcumin over native curcumin in terms of quantity and efficacy. It is also important to know how effectively nanocurcumin can work in biological systems based on pharmacokinetic and pharmacodynamic tools. For this, different types of carrier vehicles, such as lipid nanoparticles and polymeric nanoparticles, can be used to increase the bioavailability of curcumin. The utilization of novel formulations of curcumin in medical and veterinary applications may improve the health status of humans as well as the sustainable production of farm animals. In addition, its use might help minimize the excessive use of antibiotics in biomedical applications.

This Special Issue intends to focus on research articles and review papers covering recent progress and achievements in curcumin research in both human and animal science.

Prof. Dr. Taesun Min
Dr. Adhimoolam Karthikeyan
Dr. Mohammad Moniruzzaman
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• curcumin
• biotechnology
• pharmacology
• nanospheres
• nanocarriers
• drug delivery
• human
• aquatic animal
• terrestrial animal
• in vitro study
• in vivo study